Turkish Journal of Hematology
ISSN 1300-7777 · Galenos Yayinevi · Turkey · active 2001–2026
Metrics
- Scimago quartile (2025)
- Q3
- Cites per paper (2y)
- 0.8
- SJR
- 0.509
- h-index
- 31
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 18 October 2026 (venue index build).
Scimago Journal Rank 2025
In the Scimago Journal Rank 2025 edition, Turkish Journal of Hematology is Q3 in Hematology (#86 of 151 journals).
| Subject category | Quartile | Rank in category |
|---|---|---|
| Hematology | Q3 | #86 of 151 |
- Cites per document (2 years, Scopus)
- 0.70
- Documents indexed in 2025 (Scopus)
- 67
The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).
Turkish Journal of Hematology is Q3 in Hematology (2025 edition, #86 of 151 journals), with SJR 0.509 (Scimago) and an h-index of 31 (OpenAlex). Listed in DOAJ, Scopus, Web of Science, PubMed, TR Dizin.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Responding time
- Submission to publication
- ~33 wkDOAJ self-reported
Turnaround figures are indicative, not a guarantee: DOAJ values are self-reported by the journal (average weeks, submission to publication); library estimates are medians of the received/accepted dates printed in papers we hold. Editorial times vary by article type and season — confirm on the journal’s own site.
Indexing & access
- Indexed in
- DOAJScopusWeb of SciencePubMedTR Dizin
- Access status:
- gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Turkish Journal of Hematology a predatory journal?
Our screening does not flag Turkish Journal of Hematology. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, TR Dizin, which is a positive signal.
Is Turkish Journal of Hematology indexed in Scopus or Web of Science?
Per our venue index, Turkish Journal of Hematology appears in: DOAJ, Scopus, Web of Science, PubMed, TR Dizin. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Turkish Journal of Hematology?
Papers in Turkish Journal of Hematology are cited about 0.8 times each within two years of publication, and Scimago places it in Q3, with an h-index of 31. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Turkish Journal of Hematology (Q1, Q2, Q3, or Q4)?
In the Scimago Journal Rank 2025 edition, Turkish Journal of Hematology is Q3 in Hematology (#86 of 151 journals). Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Turkish Journal of Hematology is cited about 0.8 times per paper over two years, with an h-index of 31.
What is the Web of Science (JCR) quartile of Turkish Journal of Hematology?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Turkish Journal of Hematology. The open equivalent is its Scimago quartile, Q3, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Turkish Journal of Hematology open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
How long does Turkish Journal of Hematology take to publish a paper?
Submission to publication for Turkish Journal of Hematology takes about ~33 wk — DOAJ self-reported. Treat it as indicative rather than a guarantee: editorial times vary by article type, reviewer availability and season, and a self-reported figure is the journal's own. We do not hold a peer-review acceptance rate for Turkish Journal of Hematology.
Ready to submit? Tools for your next paper
Similar venues
- Transfusion MedicineQ3 · Wiley
- Blood Coagulation & FibrinolysisQ3 · Lippincott Williams & Wilkins
- Journal of Pediatric Hematology/OncologyQ3 · Lippincott Williams & Wilkins
- HämostaseologieQ3 · Thieme Medical Publishers (Germany)
- Acta Haematologica PolonicaQ4 · De Gruyter Open
- Japanese Journal of Thrombosis and Hemostasis— · Japanese Society on Thrombosis and Hemostasis
Compare it with its peers: Ranked Genetics journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.